| 1 |
35134504 | Efficacy of piperacillin-tazobactam and cefotaxime against Escherichia coli hyperproducing TEM-1 in a mouse peritonitis infection model. | 2022 Apr |
1 |
| 2 |
31923568 | Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance. | 2020 Mar |
1 |
| 3 |
24449780 | Post-β-lactamase-inhibitor effect of tazobactam in combination with ceftolozane on extended-spectrum-β-lactamase-producing strains. | 2014 |
1 |
| 4 |
14534312 | Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130. | 2003 Dec 26 |
1 |
| 5 |
9044033 | pH effects on the inhibition of extended-spectrum and classical TEM beta-lactamases by penicillanic acid sulphones. | 1997 Jan |
1 |
| 6 |
9527373 | [Characterization of the resistance to combinations of beta lactams and inhibitors of beta-lactamases in Escherichia coli. Effect of the type and amount of beta-lactamase production]. | 1997 Nov |
1 |
| 7 |
7640670 | A piperacillin-tazobactam resistant Escherichia coli strain isolated from a faecal sample of a healthy volunteer. | 1995 Apr |
1 |
| 8 |
8257123 | Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. | 1993 Oct |
1 |
| 9 |
1661596 | Beta-lactamase inhibitors: relation between kinetic data and in-vitro synergism studies. | 1991 Oct |
1 |
| 10 |
2558615 | Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam. | 1989 Nov |
1 |